<s>
The_AT aims_NN2 of_IO the_AT experiment_NN1 are_VBR to_TO determine_VVI the_AT HA_UH (_( haemagglutinin_NN1 )_) titre_NN1 of_IO a_AT1 virus_NN1 stock_NN1 ,_, to_TO identify_VVI that_DD1 virus_NN1 on_II the_AT basis_NN1 of_IO reactivity_NN1 with_IW known_JJ antisera_NN1 and_CC to_TO determine_VVI the_AT HI_UH (_( Haemagglutination_NN1 inhibition_NN1 )_) titre_NN1 of_IO the_AT specifically_RR reactive_JJ serum_NN1 by_II the_AT combination_NN1 of_IO the_AT HA_UH and_CC HI_UH assays_NN2 ._. 
</s>
<s>
Using_VVG haemagglutination_NN1 property_NN1 of_IO certain_JJ viruses_NN2 and_CC end_VV0 point_NN1 dilution_NN1 ,_, the_AT concentration_NN1 or_CC dilution_NN1 of_IO virus_NN1 required_VVN to_TO give_VVI the_AT last_MD positive_JJ haemagglutination_NN1 ,_, or_CC the_AT end_NN1 point_NN1 dilution_NN1 was_VBDZ determined_VVN ._. 
</s>
<s>
This_DD1 end_NN1 point_NN1 dilution_NN1 gives_VVZ the_AT HA_UH titre_NN1 of_IO the_AT virus_NN1 ,_, which_DDQ was_VBDZ 6400_MC HA_UH units/ml_FU and_CC there_EX was_VBDZ 2.88_MC x_ZZ1 10_MC 10_MC virus_NN1 particles/ml_FU ._. 
</s>
<s>
Using_VVG this_DD1 HA_UH titre_NN1 of_IO the_AT virus_NN1 ,_, a_AT1 stock_NN1 of_IO diluted_JJ virus_NN1 containing_VVG approximately_RR 160_MC HA_UH units/ml_FU was_VBDZ prepared_VVN ._. 
</s>
<s>
As_CSA antibodies_NN2 are_VBR specific_JJ ,_, this_DD1 precise_JJ haemagglutination_NN1 prevention_NN1 was_VBDZ used_VVN to_TO identify_VVI the_AT virus_NN1 present_NN1 ._. 
</s>
<s>
Similar_JJ to_II HA_UH titre_NN1 determination_NN1 ,_, the_AT concentration_NN1 or_CC dilution_NN1 of_IO antibody_NN1 required_VVN to_TO just_RR prevent_VVI haemagglutination_NN1 was_VBDZ determined_VVN ._. 
</s>
<s>
This_DD1 is_VBZ known_VVN haemagglutination_NN1 inhibition_NN1 (_( HI_UH )_) titre_NN1 and_CC from_II this_DD1 ,_, the_AT HI_UH titre_NN1 of_IO antiserum_NN1 was_VBDZ 3200_MC HI_UH units/ml_FU ._. 
</s>
<s>
The_AT virus_NN1 was_VBDZ given_VVN was_VBDZ identified_VVN as_CSA influenza_NN1 A_ZZ1 virus_NN1 ._. 
</s>
<s>
Each_DD1 virus_NN1 has_VHZ a_AT1 protein_NN1 coat_NN1 surrounding_VVG the_AT nucleic_JJ acid_NN1 called_VVN a_AT1 capsid_NN1 ,_, which_DDQ in_II turn_NN1 is_VBZ surrounded_VVN by_II an_AT1 envelope_NN1 ._. 
</s>
<s>
Sometimes_RT ,_, the_AT envelope_NN1 can_VM be_VBI covered_VVN by_II spikes_NN2 ,_, which_DDQ are_VBR carbohydrate_NN1 and_CC protein_NN1 complexes_NN2 ,_, projecting_VVG out_RP into_II space_NN1 from_II the_AT surface_NN1 of_IO the_AT envelope_NN1 ._. 
</s>
<s>
These_DD2 spikes_NN2 exploit_VV0 the_AT presence_NN1 of_IO cell-surface_JJ carbohydrates_NN2 ,_, principally_RR associated_VVN with_IW protein_NN1 (_( glycoprotein_NN1 )_) and_CC used_VVD them_PPHO2 for_IF attachment_NN1 and_CC thus_RR entry_NN1 into_II the_AT host_NN1 cell_NN1 ._. 
</s>
<s>
When_CS they_PPHS2 attach_VV0 to_II the_AT surface_NN1 of_IO red_JJ blood_NN1 cells_NN2 (_( RBC_NP1 )_) ,_, they_PPHS2 cause_VV0 agglutination_NN1 of_IO the_AT RBC_NP1 ._. 
</s>
<s>
This_DD1 clumping_NN1 of_IO red_JJ blood_NN1 cells_NN2 to_II each_PPX221 other_PPX222 in_II the_AT presence_NN1 of_IO certain_JJ viruses_NN2 ,_, bacteria_NN2 ,_, plant_NN1 proteins_NN2 ,_, or_CC antibodies_NN2 is_VBZ known_VVN as_II haemagglutination_NN1 and_CC the_AT viral_JJ protein_NN1 responsible_JJ is_VBZ known_VVN as_II a_AT1 haemagglutinin_NN1 (_( HA_UH )_) ._. 
</s>
<s>
Agglutination_NN1 is_VBZ due_II21 to_II22 the_AT presence_NN1 of_IO multiple_JJ binding_JJ sites_NN2 on_II the_AT virus_NN1 and_CC the_AT host_NN1 cell_NN1 (_( RBC_NP1 in_II this_DD1 case_NN1 )_) for_IF each_PPX221 other_PPX222 ._. 
</s>
<s>
As_CSA this_DD1 attachment_NN1 ,_, causing_VVG haemagglutination_NN1 is_VBZ specific_JJ and_CC unpredictable_JJ ,_, it_PPH1 can_VM be_VBI used_VVN as_II a_AT1 diagnostic_JJ tool_NN1 ._. 
</s>
<s>
For_REX21 example_REX22 ,_, influenza_NN1 virus_NN1 attach_VV0 to_II red_JJ blood_NN1 cells_NN2 (_( RBC_NP1 )_) to_TO form_VVI haemagglutination_NN1 ,_, which_DDQ can_VM easily_RR be_VBI seen_VVN with_IW naked_JJ eye_NN1 ._. 
</s>
<s>
Another_DD1 method_NN1 of_IO virus_NN1 identification_NN1 is_VBZ through_II a_AT1 known_JJ antiserum_NN1 ._. 
</s>
<s>
An_AT1 antiserum_NN1 blocks_VVZ the_AT attachment_NN1 of_IO the_AT virus_NN1 to_II the_AT host_NN1 cell_NN1 and_CC prevents_VVZ haemagglutination_NN1 ._. 
</s>
<s>
Just_RR as_CSA haemagglutination_NN1 is_VBZ precise_JJ ,_, antibodies_NN2 preventing_VVG the_AT attachments_NN2 of_IO the_AT viruses_NN2 to_II the_AT cell-surface_JJ receptors_NN2 of_IO red_JJ blood_NN1 cells_NN2 (_( RBC_NP1 )_) is_VBZ specific_JJ and_CC this_DD1 property_NN1 form_VV0 the_AT basis_NN1 of_IO the_AT haemagglutination_NN1 inhibition_NN1 (_( HI_UH )_) assay_NN1 and_CC can_VM be_VBI used_VVN to_TO identify_VVI an_AT1 unknown_JJ virus_NN1 ._. 
</s>
<s>
The_AT specificity_NN1 of_IO haemagglutination_NN1 lies_VVZ in_II the_AT interaction_NN1 between_II the_AT virus_NN1 and_CC the_AT host_NN1 cell_NN1 's_GE surface_NN1 ._. 
</s>
<s>
The_AT virus_NN1 binds_VVZ to_II receptors_NN2 on_II the_AT host_NN1 cell_NN1 and_CC as_CSA these_DD2 receptors_NN2 or_CC domains_NN2 differ_VV0 in_II shape_NN1 and_CC complexity_NN1 ,_, a_AT1 type_NN1 of_IO virus_NN1 can_VM only_RR interact_VVI with_IW certain_JJ host_NN1 cells_NN2 ._. 
</s>
<s>
This_DD1 brought_VVD about_RP this_DD1 precise_JJ interaction_NN1 ._. 
</s>
<s>
There_EX are_VBR two_MC main_JJ domains_NN2 :_: a_AT1 complex_JJ polypeptide_NN1 motif_NN1 or_CC a_AT1 simpler_JJR carbohydrate_NN1 motif_NN1 ._. 
</s>
<s>
In_II haemagglutination_NN1 ,_, it_PPH1 is_VBZ due_II21 to_II22 binding_VVG to_II a_AT1 carbohydrate_NN1 motif_NN1 ._. 
</s>
<s>
Furthermore_RR ,_, the_AT haemagglutination_NN1 can_VM be_VBI used_VVN to_TO determine_VVI the_AT original_JJ amount_NN1 or_CC concentration_NN1 of_IO virus_NN1 or_CC antibody_NN1 in_II the_AT stock_NN1 ._. 
</s>
<s>
The_AT original_JJ stock_NN1 is_VBZ serially_RR diluted_VVN and_CC the_AT size_NN1 of_IO agglutination_NN1 of_IO the_AT RBCs_NP1 is_VBZ compared_VVN to_II find_VV0 the_AT end_NN1 point_NN1 ,_, where_RRQ there_EX is_VBZ only_RR a_AT1 slight_JJ haemagglutination_NN1 ._. 
</s>
<s>
Further_JJR dilution_NN1 will_NN1 results_NN2 in_II inadequate_JJ amount_NN1 of_IO virus_NN1 to_TO cause_VVI agglutination_NN1 ._. 
</s>
<s>
The_AT amount_NN1 of_IO virus_NN1 which_DDQ just_RR able_JK to_TO agglutinate_VVI a_AT1 fixed_JJ number_NN1 of_IO RBCs_NP1 is_VBZ defined_VVN as_CSA 1_MC1 HA_UH unit_NN1 of_IO virus_NN1 and_CC the_AT concentration_NN1 of_IO virus_NN1 per_II volume_NN1 can_VM be_VBI calculated_VVN and_CC thus_RR the_AT HA_UH titre_NN1 of_IO the_AT undiluted_JJ stock_NN1 determined_VVN ._. 
</s>
<s>
The_AT same_DA method_NN1 is_VBZ used_VVN to_TO determine_VVI the_AT HI_UH titre_NN1 ,_, which_DDQ is_VBZ one_PN1 HI_UH unit_NN1 of_IO antiserum_NN1 per_II reaction_NN1 volume_NN1 at_II which_DDQ HA_UH inhibition_NN1 is_VBZ last_MD seen_VVN ._. 
</s>
<s>
All_DB the_AT steps_NN2 in_II the_AT laboratory_NN1 manual_NN1 were_VBDR followed_VVN ._. 
</s>
<s>
To_II all_DB the_AT wells_NN2 25_MC l_NNU of_IO blood_NN1 from_II the_AT same_DA container_NN1 was_VBDZ added_VVN ._. 
</s>
<s>
In_II the_AT determination_NN1 of_IO HA_UH titre_NN1 ,_, the_AT control_NN1 (_( C_ZZ1 )_) used_VVD contain_VV0 100_MC l_NNU of_IO PBS_NP1 and_CC 25_MC l_NNU of_IO blood_NN1 but_CCB no_AT virus_NN1 ._. 
</s>
<s>
The_AT first_MD well_NN1 (_( 1_MC1 )_) contained_VVD the_AT 10-fold_JJ dilution_NN1 of_IO the_AT original_JJ virus_NN1 stock_NN1 and_CC the_AT subsequent_JJ wells_NN2 were_VBDR 2-fold_JJ dilutions_NN2 (_( 2_MC to_II 12_MC )_) ._. 
</s>
<s>
In_II the_AT determination_NN1 of_IO the_AT HI_UH titre_NN1 ,_, 4_MC different_JJ controls_NN2 were_VBDR used_VVN and_CC the_AT original_JJ virus_NN1 is_VBZ diluted_VVN to_TO contain_VVI approximately_RR 160_MC HA_UH units/ml._FU 50_MC l_NNU of_IO the_AT original_JJ virus_NN1 stock_NN1 and_CC 1950_MC l_NNU of_IO PBS_NP1 were_VBDR mixed_VVN to_TO obtain_VVI the_AT required_JJ 160_MC HA_UH units/ml_FU of_IO virus_NN1 ._. 
</s>
<s>
The_AT first_MD control_NN1 (_( C1_FO )_) contained_VVD 100_MC l_NNU of_IO PBS_NP1 and_CC 25_MC l_NNU of_IO the_AT diluted_JJ virus_NN1 but_CCB no_AT antibody_NN1 ._. 
</s>
<s>
The_AT second_MD control_NN1 (_( C2_FO )_) contained_VVD 100_MC l_NNU of_IO PBS_NP1 and_CC 10_MC l_NNU of_IO antibody_NN1 X_ZZ1 but_CCB no_AT virus_NN1 ._. 
</s>
<s>
The_AT third_MD control_NN1 (_( C3_FO )_) contained_VVD 100_MC l_NNU of_IO PBS_NP1 and_CC 10_MC l_NNU of_IO antibody_NN1 Y_ZZ1 but_CCB no_AT virus_NN1 ._. 
</s>
<s>
To_II the_AT last_MD control_NN1 (_( C4_FO )_) ,_, only_RR 100_MC l_NNU of_IO PBS_NP1 was_VBDZ added_VVN with_IW neither_RR of_IO the_AT antibodies_NN2 nor_CC the_AT virus_NN1 ._. 
</s>
<s>
All_DB the_AT X_ZZ1 and_CC Y_ZZ1 wells_NN2 contain_VV0 100_MC l_NNU of_IO PBS_NP1 ,_, 25_MC l_NNU of_IO diluted_JJ virus_NN1 and_CC 10_MC l_NNU of_IO the_AT respective_JJ antibody_NN1 ._. 
</s>
<s>
From_II table_NN1 1_MC1 ,_, the_AT 7_MC th_NNU wells_NN2 in_II both_DB2 row_VV0 A_ZZ1 and_CC B_ZZ1 (_( duplicates_NN2 )_) contain_VV0 the_AT most_RGT dilute_JJ positive_JJ sample_NN1 ,_, the_AT HA_UH titre_NN1 of_IO original_JJ virus_NN1 stock_NN1 is_VBZ therefore_RR ,_, 6400_MC HA_UH units/ml_FU ._. 
</s>
<s>
The_AT first_MD well_NN1 is_VBZ a_AT1 10-fold_JJ dilution_NN1 ,_, and_CC the_AT second_MD well_NN1 is_VBZ a_AT1 20-fold_JJ dilution_NN1 and_CC the_AT third_MD well_NN1 is_VBZ a_AT1 40-fold_JJ dilution_NN1 ,_, therefore_RR the_AT seventh_MD well_NN1 is_VBZ a_AT1 640-fold_JJ dilution_NN1 of_IO the_AT original_JJ virus_NN1 stock_NN1 ._. 
</s>
<s>
Refer_VV0 to_II the_AT appendix_NN1 for_IF calculations_NN2 ._. 
</s>
<s>
From_II table_NN1 2_MC ,_, the_AT 6_MC th_NNU wells_NN2 in_II row_NN1 X_ZZ1 1_MC1 and_CC X_ZZ1 2_MC (_( duplicates_NN2 )_) were_VBDR seen_VVN to_TO contain_VVI the_AT most_RGT dilute_JJ positive_JJ sample_NN1 ._. 
</s>
<s>
As_II the_AT 6_MC th_NNU wells_NN2 were_VBDR 320-fold_JJ dilutions_NN2 ,_, the_AT original_JJ undiluted_JJ antibody_NN1 stock_NN1 contains_VVZ 3200_MC HI_UH unit/ml_FU ._. 
</s>
<s>
Refer_VV0 to_II the_AT appendix_NN1 for_IF calculations_NN2 and_CC the_AT method_NN1 for_IF the_AT contents_NN2 of_IO each_DD1 well_NN1 ._. 
</s>
<s>
As_CSA antibody_NN1 Y_NP1 did_VDD not_XX inhibit_VVI agglutination_NN1 of_IO RBC_NP1 ,_, it_PPH1 is_VBZ not_XX the_AT antibody_NN1 for_IF the_AT virus_NN1 provided_VVD ._. 
</s>
<s>
Therefore_RR the_AT virus_NN1 was_VBDZ concluded_VVN as_CSA influenza_NN1 A_ZZ1 virus_NN1 as_CSA it_PPH1 was_VBDZ known_VVN that_DD1 antibody_NN1 X_ZZ1 contains_VVZ the_AT antiserum_NN1 for_IF influenza_NN1 A_ZZ1 virus_NN1 ._. 
</s>
<s>
The_AT amount_NN1 of_IO virus_NN1 just_RR able_JK to_TO agglutinate_VVI a_AT1 fixed_JJ number_NN1 of_IO RBCs_NP1 is_VBZ defined_VVN as_CSA 1HA_FO of_IO virus_NN1 and_CC at_II the_AT end_NN1 points_NN2 (_( refer_VV0 to_II table_NN1 1_MC1 and_CC 2_MC )_) ,_, there_EX is_VBZ a_AT1 virus_NN1 concentration_NN1 of_IO 1_MC1 HA_UH units/ml_FU ._. 
</s>
<s>
The_AT end_NN1 points_NN2 were_VBDR clearly_RR observed_VVN in_II table_NN1 1_MC1 (_( 7_MC th_NNU well_RR )_) and_CC table_NN1 2_MC (_( 6_MC th_NNU well_NN1 of_IO X_ZZ1 rows_NN2 )_) and_CC they_PPHS2 r_ZZ1 the_AT wells_NN2 where_RRQ agglutination_NN1 was_VBDZ just_RR observed_VVN ._. 
</s>
<s>
If_CS there_EX were_VBDR too_RG many_DA2 virus_NN1 present_NN1 ,_, agglutination_NN1 would_VM take_VVI place_NN1 and_CC the_AT whole_JJ well_NN1 would_VM be_VBI almost_RR homogenously_RR red_JJ ._. 
</s>
<s>
If_CS too_RG little_DA1 or_CC no_AT virus_NN1 were_VBDR present_JJ ,_, the_AT RBCs_NP1 will_VM settle_VVI to_II the_AT bottom_NN1 of_IO the_AT well_NN1 resulting_VVG in_II a_AT1 bright_JJ pink/red_JJ spot_NN1 at_II the_AT bottom_NN1 of_IO the_AT well_NN1 ._. 
</s>
<s>
If_CS little_JJ or_CC no_AT antibody_NN1 is_VBZ present_JJ ,_, it_PPH1 will_VM behave_VVI the_AT same_DA as_CSA the_AT presence_NN1 of_IO numerous_JJ viruses_NN2 and_CC a_AT1 homogenous_JJ red_JJ well_NN1 would_VM be_VBI observed_VVN ._. 
</s>
<s>
In_II the_AT HA_UH assay_NN1 ,_, the_AT 7_MC th_NNU well_NN1 was_VBDZ taken_VVN as_II the_AT end_NN1 point_NN1 as_CSA further_JJR dilution_NN1 resulted_VVN in_II inadequate_JJ amount_NN1 of_IO virus_NN1 to_TO cause_VVI agglutination_NN1 ._. 
</s>
<s>
This_DD1 is_VBZ shown_VVN in_II well_RR 7_MC of_IO table_NN1 1_MC1 ._. 
</s>
<s>
From_II this_DD1 ,_, the_AT original_JJ stock_NN1 was_VBDZ calculated_VVN to_TO contain_VVI 6400_MC HA_UH units_NN2 of_IO virus/ml_FU and_CC therefore_RR had_VHN 2.88_MC x_ZZ1 10_MC 10_MC virus_NN1 particles/ml_FU ._. 
</s>
<s>
In_II the_AT HI_UH assay_NN1 ,_, the_AT 6_MC th_NNU well_NN1 was_VBDZ taken_VVN as_II the_AT end_NN1 point_NN1 as_CSA further_JJR dilution_NN1 resulted_VVN in_II inadequate_JJ amount_NN1 of_IO antibody_NN1 and_CC thus_RR cause_VV0 agglutination_NN1 of_IO RBCs_NP1 as_II the_AT amount_NN1 of_IO antibody_NN1 present_NN1 fails_VVZ to_TO inhibit_VVI most_DAT of_IO the_AT virus_NN1 from_II attaching_VVG to_II cell_NN1 surface_NN1 ._. 
</s>
<s>
This_DD1 is_VBZ shown_VVN in_II well_RR 6_MC of_IO X_ZZ1 rows_NN2 of_IO table_NN1 2_MC ._. 
</s>
<s>
Since_CS antibody_NN1 Y_NP1 did_VDD not_XX prevent_VVI the_AT agglutination_NN1 of_IO RBCs_NP1 ,_, the_AT virus_NN1 was_VBDZ concluded_VVN as_CSA not_XX being_VBG para_NN1 influenza_NN1 virus_NN1 Type_NN1 3_MC ._. 
</s>
<s>
In_II the_AT 6_MC th_NNU wells_NN2 of_IO both_DB2 of_IO the_AT row_NN1 X_ZZ1 ,_, the_AT end_NN1 points_NN2 were_VBDR observed_VVN and_CC further_JJR dilutions_NN2 of_IO the_AT antibody_NN1 suspension_NN1 resulted_VVN in_II agglutination_NN1 of_IO the_AT RBCs_NP1 and_CC therefore_RR ,_, the_AT known_JJ virus_NN1 was_VBDZ identified_VVN as_CSA influenza_NN1 virus_NN1 A._NNU During_II the_AT transferring_NN1 of_IO samples_NN2 across_II the_AT wells_NN2 ,_, the_AT pipettes_NN2 used_VVN might_VM not_XX be_VBI very_RG accurate_JJ ,_, resulting_VVG in_II incorrect_JJ dilutions_NN2 ._. 
</s>
<s>
For_IF proper_JJ agglutination_NN1 to_TO occur_VVI the_AT RBCs_NP1 must_VM be_VBI thoroughly_RR mixed_VVN with_IW the_AT virus_NN1 suspension_NN1 in_II the_AT wells_NN2 and_CC failure_NN1 to_TO do_VDI so_RR will_VM not_XX result_VVI in_II haemagglutination_NN1 ._. 
</s>
<s>
Furthermore_RR ,_, the_AT viruses_NN2 needed_VVD a_AT1 rather_RG significant_JJ amount_NN1 of_IO time_NNT1 to_TO attach_VVI to_II the_AT surface_NN1 of_IO the_AT RBCs_NP1 ._. 
</s>
<s>
If_CS the_AT RBCs_NP1 were_VBDR not_XX given_VVN enough_DD time_NNT1 to_TO settle_VVI down_RP to_II the_AT bottom_NN1 of_IO the_AT well_NN1 or_CC if_CS the_AT RBCs_NP1 were_VBDR lysed_VVN a_AT1 cloudy_JJ pink_JJ suspension_NN1 might_VM be_VBI obtained_VVN instead_RR ._. 
</s>
<s>
It_PPH1 was_VBDZ rather_RG difficult_JJ to_TO determine_VVI the_AT end_NN1 point_NN1 as_CSA it_PPH1 was_VBDZ subject_II21 to_II22 personal_JJ options_NN2 and_CC thus_RR the_AT dilution_NN1 factor_NN1 of_IO the_AT end_NN1 point_NN1 would_VM be_VBI different_JJ ._. 
</s>
<s>
As_II the_AT wells_NN2 were_VBDR left_VVN for_IF different_JJ amount_NN1 of_IO time_NNT1 ,_, a_AT1 comparative_JJ test_NN1 among_II them_PPHO2 would_VM not_XX be_VBI very_RG accurate_JJ ._. 
</s>
<s>
In_II conclusion_NN1 ,_, the_AT virus_NN1 was_VBDZ identified_VVN as_CSA influenza_NN1 virus_NN1 A._NP1 The_AT HA_UH titre_NN1 of_IO the_AT virus_NN1 was_VBDZ 6400_MC HA_UH units/ml_FU and_CC there_EX was_VBDZ 2.88_MC x_ZZ1 10_MC 10_MC virus_NN1 particles/ml_FU in_II this_DD1 original_JJ undiluted_JJ virus_NN1 stock_NN1 ._. 
</s>
<s>
The_AT HI_UH titre_NN1 of_IO antiserum_NN1 was_VBDZ 3200_MC HI_UH units/ml_FU ._. 
</s>
